ARTICLE | Clinical News
Forodesine regulatory update
August 30, 2004 7:00 AM UTC
FDA granted Orphan Drug designation to BCRX for its forodesine to treat chronic lymphocytic leukemia (CLL) and related leukemias, including prolymphocytic leukemia, adult T cell leukemia, and hairy ce...